Bimekizumab Impact on Patient-Reported Outcomes in Plaque Psoriasis: 4-Year Results from BE SURE, BE VIVID, BE READY, and BE BRIGHT

Authors

Institutions

Publication Details

Journal
Dermatology and Therapy
Published
2025-12-08
DOI
https://doi.org/10.1007/s13555-025-01595-9
Primary Topic
Psoriasis: Treatment and Pathogenesis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Bimekizumab Impact on Patient-Reported Outcomes in Plaque Psoriasis: 4-Year Results from BE SURE, BE VIVID, BE READY, and BE BRIGHT

Kim Papp, José M. López Pinto, Keiichi Yamanaka, Jérémy Lambert et al.
Dermatology and Therapy
Psoriasis: Treatment and Pathogenesis
article

Bimekizumab Impact on Patient-Reported Outcomes in Plaque Psoriasis: 4-Year Results from BE SURE, BE VIVID, BE READY, and BE BRIGHT

Kim Papp, José M. López Pinto, Keiichi Yamanaka, Jérémy Lambert, Krista Wixted, L. Savage, Diamant Thaçi, Rhys Warham, April W. Armstrong, Mark Lebwohl, Diana Elena Vlase
article en

Abstract

No abstract available for this paper.
Dermatology and TherapyVol. 16(1)
APLA Health (US), University of California, Los Angeles (US), Mie University (JP), University of Toronto (CA), Leeds Teaching Hospitals NHS Trust (GB), UCB Pharma (France) (FR), Probity Medical Research (CA), Digital Research Alliance of Canada, National Patient Safety Foundation (US), University of Lübeck (DE), Icahn School of Medicine at Mount Sinai (US)
Openalex Percentile: Top 56%
Psoriasis: Treatment and Pathogenesis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.